Should patients with anaplastic oligodendroglial tumors receive adjuvant chemotherapy?

被引：0
作者：
Gilbert, M. R.
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA
来源：
NATURE CLINICAL PRACTICE NEUROLOGY | 2007年 / 3卷 / 01期
关键词：
anaplastic oligodendroglioma; chemotherapy; molecular marker; randomized trial;
D O I：
10.1038/ncpneuro0375
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：14 / 15
页数：2
相关论文
共 5 条
[1]   Factors influencing survival in high-grade gliomas [J].
Buckner, JC .
SEMINARS IN ONCOLOGY, 2003, 30 (06) :10-14
[2]   Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss [J].
Ino, Y ;
Zlatescu, MC ;
Sasaki, H ;
MacDonald, DR ;
Stemmer-Rachamimov, AO ;
Jhung, S ;
Ramsay, DA ;
von Deimling, A ;
Louis, DN ;
Cairncross, JG .
JOURNAL OF NEUROSURGERY, 2000, 92 (06) :983-990
[3]   Current strategies in treatment of oligodendroglioma: Evolution of molecular signatures of response [J].
Jaeckle, KA ;
Ballman, KV ;
Rao, RD ;
Jenkins, RB ;
Buckner, JC .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (08) :1246-1252
[4]   SUCCESSFUL CHEMOTHERAPY FOR NEWLY DIAGNOSED AGGRESSIVE OLIGODENDROGLIOMA [J].
MACDONALD, DR ;
GASPAR, LE ;
CAIRNCROSS, JG .
ANNALS OF NEUROLOGY, 1990, 27 (05) :573-574
[5]   Recent advances in the treatment of malignant astrocytoma [J].
Reardon, DA ;
Rich, JN ;
Friedman, HS ;
Bigner, DD .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (08) :1253-1265
1